Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Dec 21, 2021
Open Peer Review Period: Dec 17, 2021 - Dec 31, 2021
Date Accepted: Oct 23, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Patterns of HIV or AIDS Mortality Among Older People From 1990 to 2019 in China: Age-Period-Cohort Analysis

Ren N, Li Y, Wan Z, Wang R, Zhang W, Dzakah EE, Zhang J, Li A, Fan S

Patterns of HIV or AIDS Mortality Among Older People From 1990 to 2019 in China: Age-Period-Cohort Analysis

JMIR Public Health Surveill 2022;8(11):e35785

DOI: 10.2196/35785

PMID: 36394944

PMCID: 9716424

Patterns of HIV/AIDS mortality among the elderly from 1990-2019 in China: age-period-cohort analysis

  • Ningjun Ren; 
  • Yuansheng Li; 
  • Zhengwei Wan; 
  • Ruolan Wang; 
  • Wenxin Zhang; 
  • Emmanuel Enoch Dzakah; 
  • Junhui Zhang; 
  • Ailing Li; 
  • Song Fan

ABSTRACT

Background:

With the increasing effectiveness of antiretroviral therapy and shifting demographics, the problem of elder people with HIV and AIDS is increasingly grim in China, and neglecting infection among elders may cause more serious social problems, exacerbating the difficulty of controlling HIV transmission and raise the risk of death.

Objective:

We investigated the variations in the trends of Chinese mortality by age, period, and cohort from 1990 to 2019,to reveal the relationship between age-period-cohort and HIV burden and guidance for resource allocation to prevent HIV-related deaths in vulnerable target populations.

Methods:

We extracted the HIV/AIDS mortality data from the Globe Burden of Disease (GBD 2019) and online databases published by governments. The Joinpoint regression model was applied to detect changes in HIV/AIDS trends. The age–period–cohort model was used to explore the age, period, and cohort effects.

Results:

The trends in age-standardized HIV/AIDS mortality rates were increased in both genders, from .50 to 4.54 per 100,000 individuals for males and .19 to 1.43 per 100,000 individuals for females. Joinpoint regression model showed the average annual percentage change of standardized mortality rate (AAPC) was 7.0 for males and 6.4 for females, showing an increasing trend. The age effect of males' HIV/AIDs mortality showed a net increase of .59 = [(-.21) ~ .38], from the age of 50-79 years. There is a gradual upward trend in the change in risk of death from AIDS for the period effect among the older population, lowest at ages 50-54 (-.80 for males; -.78 for females) and highest at ages 75-79 (.86 for males; .69 for females). The variation of cohort effects was complex, but both genders had a nearly consistent tendency; people born in 1920-1929 had the lowest cohort effect, born in 1950-1954 had the highest values.

Conclusions:

Our study showed a marked rise in HIV mortality for both genders in China from 1990 to 2019. Aging is an important issue in current HIV prevention and control. There is an urgent need to promote HIV testing and health education. Our findings will help predict future changes in HIV/AIDS mortality and identify age-specific priority populations for intervention


 Citation

Please cite as:

Ren N, Li Y, Wan Z, Wang R, Zhang W, Dzakah EE, Zhang J, Li A, Fan S

Patterns of HIV or AIDS Mortality Among Older People From 1990 to 2019 in China: Age-Period-Cohort Analysis

JMIR Public Health Surveill 2022;8(11):e35785

DOI: 10.2196/35785

PMID: 36394944

PMCID: 9716424

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.